Roche Holding Ltd. Share Price Swiss Exchange
Equities
CH0012032048
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
Sales 2024 * | 60.04B 65.29B 5,227B | Sales 2025 * | 63.8B 69.39B 5,555B | Capitalization | 178B 194B 15,500B |
---|---|---|---|---|---|
Net income 2024 * | 13.27B 14.43B 1,155B | Net income 2025 * | 14.75B 16.04B 1,284B | EV / Sales 2024 * | 3.2 x |
Net Debt 2024 * | 14.24B 15.49B 1,240B | Net Debt 2025 * | 8.17B 8.88B 711B | EV / Sales 2025 * | 2.92 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
11.7
x | Employees | - |
Yield 2024 * |
4.41% | Yield 2025 * |
4.56% | Free-Float | 88.91% |
Latest transcript on Roche Holding Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 31/12/02 | |
Severin Schwan
CHM | Chairman | 57 | 31/12/07 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 31/03/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 02/03/15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 31/12/95 |
1st Jan change | Capi. | |
---|---|---|
+33.17% | 704B | |
+28.63% | 577B | |
-4.28% | 348B | |
+18.43% | 327B | |
+4.87% | 288B | |
+14.70% | 234B | |
+4.93% | 198B | |
-4.40% | 147B | |
-8.41% | 145B |